Toho Holdings Co., Ltd.
Stock Price Chart
2026/08/14 UpdatedPrice Trend
2026/08/14 UpdatedPrice & Trading Details
2026/08/14 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/05/13 | ¥66.21 | ¥44.13 | -33.4% |
| 2026/02/11 | ¥117.06 | ¥127.93 | +9.3% |
| 2025/08/05 | ¥28.82 | ¥53.61 | +86.0% |
Shareholder Composition
Updated 2026/08/01Dividend History 4Years Growth
Updated 2026/08/09| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥120 | +41.2% |
| 2025 | ¥85 | +80.9% |
| 2024 | ¥47 | +38.2% |
| 2023 | ¥34 | +9.7% |
| 2022 | ¥31 | - |
Financial Performance
2026/08/09 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥1,266,171M | ¥1,392,117M | ¥1,476,712M | ¥1,518,495M |
| Gross Profit | ¥108,687M | ¥114,366M | ¥119,148M | ¥121,648M |
| Operating Income | ¥12,534M | ¥16,369M | ¥19,337M | ¥18,942M |
| Pretax Income | ¥20,186M | ¥20,492M | ¥30,845M | ¥28,102M |
| Net Income | ¥13,379M | ¥13,630M | ¥20,657M | ¥19,844M |
| EPS | ¥174.48 | ¥180.67 | ¥286.79 | ¥284.22 |
| Operating Margin | 0.99% | 1.18% | 1.31% | 1.25% |
| Balance Sheet | ||||
| Total Assets | ¥702,376M | ¥715,288M | ¥773,427M | ¥722,805M |
| Total Equity | ¥241,079M | ¥242,823M | ¥249,330M | ¥256,779M |
| Total Liabilities | ¥461,297M | ¥472,465M | ¥524,097M | ¥466,026M |
| Cash | ¥94,256M | ¥86,201M | ¥132,970M | ¥86,533M |
| Interest-bearing Debt | ¥40,737M | ¥37,888M | ¥30,244M | ¥21,260M |
| Equity Ratio | 34.32% | 33.95% | 32.24% | 35.53% |
| D/E Ratio | 0.17 | 0.16 | 0.12 | 0.08 |
| Cash Flow | ||||
| Operating CF | ¥16,341M | -¥9M | ¥59,934M | -¥26,675M |
| Investing CF | -¥11,032M | ¥4,315M | ¥9,091M | -¥4,180M |
| Financing CF | -¥4,473M | -¥13,060M | -¥22,195M | -¥20,364M |
| Free CF | ¥12,139M | -¥2,528M | ¥56,153M | -¥32,432M |
| Efficiency | ||||
| ROE | 5.55% | 5.61% | 8.29% | 7.73% |
| ROA | 1.90% | 1.91% | 2.67% | 2.75% |
Latest IR Information
-
Notice of Completion of Payment for Transfer-Restricted Stock as Treasury Stock Acquisition
Payment procedures for the disposition of treasury stock as transfer-restricted stock-based compensation have been completed. Disposed shares: 13,900, at a price of 3,982 yen per share, total amount 55,349,800 yen. Disposed to four directors (excluding audit committee members) and executives....
Read more -
Notice Regarding Absorption-type Merger with a Consolidated Subsidiary (Simplified Merger)
Toho Holdings will absorb its consolidated subsidiary Toho System Service. The surviving company will be Toho Holdings, with the merger scheduled for October 1, 2026. No stock issuance, no allotment. The impact on consolidated results is expected to be minor.
Read more -
Q1 FY2027 Earnings Summary (Japanese GAAP)
Outline of the Q1 FY2027 results. Highlights revenue, operating income, ordinary income, and quarterly net income attributable to owners of the parent, with segment trends. Explains momentum for the period and progress toward mid-term plans.
Read more -
Resolution to Dispose of Treasury Stock with Transfer Restrictions｜July 15, 2026
Toho Holdings plans to dispose of 13,900 shares of treasury stock on August 14, 2026, raising approximately 55,349,800 yen. The purpose of the disposal is to enhance shareholder value and provide long-term incentives.
Read more -
Financial Summary for the Fiscal Year Ending March 2026 [Japanese Standards] (Consolidated)
For the fiscal year ending March 2026, consolidated net sales were ¥1,553,364 million (up 2.3% YoY), operating profit was ¥166,010 million (down 12.3% YoY), and net income attributable to owners of the parent was ¥173,270 million (down 12.7% YoY).
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥4,525
Rating Score: 3.00 (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It operates in four segments: Pharmaceutical Wholesale Business, Dispensing Pharmacy Business, Pharmaceutical Manufacturing and Sales Business, and Other Peripheral Businesses. The company sells pharmaceuticals, narcotics, reagents, and medical devices to hospitals, clinics, and dispensing pharmacies. It is also involved in the management of the dispensing pharmacies business; operates health insurance pharmacy; provision of support home medical care services; peripheral businesses; core system operations; and real estate agency business. In addition, the company manufacture and sell pharmaceuticals; sells generic drugs; and manufactures injection drugs on consignment. Further, it provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. Additionally, the company offers various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE Helios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin Nex-Sus, an inventory control system for large hospitals ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition. The company was incorporated in 1948 and is headquartered in Chuo, Japan.
